查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球醫療器械外包市場
市場調查報告書
商品編碼
1153823

2022-2029 年全球醫療器械外包市場

Global Medical Device Outsourcing Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

預計2022年全球醫療器械外包市場規模將達到1125.7891億美元，2029年將達到2897.6864億美元，預測期內（2022-2029年）的複合年增長率為13.26%，有望繼續增長。

外包是指公司要求第三方執行服務或創建產品，通常是為了降低成本。醫療器械行業將醫療器械的製造和相關服務外包。外包使設備製造商能夠更快地將新產品推向市場並更快地獲得投資回報。

市場動態

推動全球醫療器械外包市場的主要因素是心血管疾病等慢性病發病率上升、製造設施數量增加、運營成本降低以及外包需求增加。

擴大製造設施和降低運營成本預計將推動市場增長。

醫療設備外包市場受到對先進產品和離岸外包趨勢不斷增長的需求的推動。這種增長將主要受到醫療設備成本上升的推動，進而需要抑制不斷增長的醫療保健支出。醫療設備製造商面臨著降低管理費用和運營成本同時保持醫療服務質量的壓力，這推動了醫療設備外包市場的發展。產品外包可以幫助降低 10-15% 的生產成本。

此外，對優質醫療保健的需求不斷上升也是推動全球醫療器械外包市場增長的關鍵因素之一。所提供的醫療保健質量取決於診斷設備的質量。這迫使醫療設備製造商將產品開發外包，以在競爭激烈的醫療保健行業中獲得優勢。

醫療設備外包市場的另一個驅動因素是各種新產品發布和設施擴建。例如，2022 年 8 月，合同研究、開發和製造組織 (CRDMO) WuXi STA 宣佈在美國特拉華州開設製藥製造園區。將在美國建立第二家工廠以滿足客戶需求。

機密信息丟失的威脅預計會阻礙市場增長。

但是，在與第三方簽訂製造、產品設計、原型製作等合同時丟失敏感信息的風險正在阻礙全球醫療設備外包市場。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了積極影響。 COVID-19 的爆發嚴重影響了醫療保健行業。由於對新穎有效的疫苗和藥物的需求增加以及臨床試驗數量的增加，醫療器械外包市場經歷了巨大的增長。各種生物製藥公司已與合同研究組織合作或合作，以滿足需求和不斷增長的研發活動。世界各地正在發生各種倡議、合作和合併，促進了市場的增長。例如，2022 年 7 月，Medidata 宣布擴大和更新與 Novotech 的合作夥伴關係，以繼續在不同治療領域進行臨床研究。利用一系列技術，包括 Medidata 的 Rave EDC、Ecoa 和 Rave RTSM，Novotec 現在擁有可配置和靈活的功能來滿足大規模臨床研究需求的工具。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 降低生產成本
      • 擴大製造基地
    • 約束因素
      • 機密信息洩露的威脅
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章副產品

  • 原材料
  • 電子產品
  • 成品

第 8 章按設備類型

  • 一級
  • 二級
  • 三級

第9章服務

  • 設備製造委託
  • 原型開發
  • 臨床研究和監管支持服務
  • 產品設計和開發
  • 產品測試
  • 組裝和包裝
  • 質量保證
  • 其他

第 10 章應用

  • 心髒病學
  • 骨科/脊柱
  • 放射科
  • 給藥
  • 眼科
  • 通用醫療設備
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第13章公司簡介

  • Integer Holdings Corporation
    • 公司簡介
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Thermo Fisher Scientific
  • Nortech Systems, Inc.
  • Plexus Corp.
  • West Pharmaceutical Services, Inc
  • Celestica, Inc
  • Intertek Group
  • Wuxi Apptec
  • IQVIA Holdings
  • Benchmark Electronic Inc.

第14章 全球醫療器械外包市場-DataM

簡介目錄
Product Code: DMMD1185

Market Overview

The global medical device outsourcing market size was valued at US$ 112,578.91 million in 2022 and is estimated to reach US$ 289,768.64 million by 2029, growing at a CAGR of 13.26% during the forecast period (2022-2029).

Outsourcing is a practice usually undertaken by companies as a cost-cutting measure by hiring a party outside a company to perform services and create goods. The medical device industry is outsourcing both the manufacturing of medical devices and associated services; outsourcing can help equipment manufacturers to accelerate their time to market for a new product and speed up return on investment.

Market Dynamics

The major factors driving the global medical device outsourcing market are the rising incidence of chronic diseases such as cardiovascular, the increasing number of manufacturing facilities, reducing operational costs and the rising demand for outsourcing.

Expanding manufacturing facilities and reducing operational costs are expected to drive the market's growth.

The medical device outsourcing market is driven by rising demand for advanced products and the trend of offshoring. This growth would be mainly led by the need to curb the rising cost of medical equipment and, thereby, healthcare expenses. An increase in pressure on the manufacturers to reduce the overhead expenses and operational costs while maintaining the quality of healthcare services is propelling the medical device outsourcing market. Product outsourcing helps in reducing production costs by 10-15%.

Additionally, the growing demand for quality healthcare is one of the key factors driving the global medical devices outsourcing market growth. The quality of healthcare delivered depends on the quality of diagnostic devices. This forces device manufacturers to outsource product development to stay ahead in the competitive healthcare industry.

Another driving factor for the medical device outsourcing market is various novel product launches and facility expansion. For instance, in Aug 2022, WuXi STA, a contract research development and manufacturing organization (CRDMO), announced its pharmaceutical manufacturing campus in Delaware, United States. A second facility in the United States to meet the demand of customers.

The threat of losing confidential information is expected to hamper the market growth.

However, the threat of losing confidential information in contracting with a third party for manufacturing, product designing, prototyping, and others is hampering the global medical device outsourcing market.

COVID-19 Impact Analysis

The pandemic has positively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The medical device outsourcing market has experienced huge profits due to the increase in demand for novel and effective vaccines and drugs and the rise in the number of clinical trials. Various biopharmaceutical companies partnered or collaborated with contract research organizations to meet the demands and growing R&D activities. Various initiatives, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Jul 2022, Medidata announced their partnership expansion and renewal with Novotech to continue clinical studies in different therapeutic areas. Leveraging various technologies such as Rave EDC, Ecoa, Rave RTSM etc., from Medidata, Novotech now has equipped tools that are configurable and flexible and address clinical research needs at a large scale.

Segment Analysis

The services segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The services segment is the highest market holder in the global medical device outsourcing market. Based on the services segment, the contract device manufacturing sub-segment holds the largest market share. The need for contract manufacturing is increasing with the need for reducing operational costs and overhead expenses with good quality services.

Manufacturers require high-quality safety gadgets, and the rising manufacturing complexity makes contract manufacturing a better choice. Furthermore, during medical device development, inspection level is getting high, resulting in multiple standards and regulations, leading to increased demand for contract device manufacturing.

The service segment dominates the market due to the rising demand for contract manufacturing and rising global incidences of chronic diseases such as cardiovascular and neurological disorders. The growing number of regulatory approvals, technological advancements, expansion, and research/clinical trial studies drive the market's growth. For instance, in Aug 2022, Plexus Corp., a product design, manufacturing and marketing services provider, announced its novel manufacturing facility opening in Bangkok, Thailand. Around $60 million is invested in constructing a 400,000 sq. ft. site. This facility will strengthen energy-efficient operational and monitoring systems supporting Plexus's environmental, social and governance mission (ESG) for the betterment of the world.

Geographical Analysis

North America holds the largest market share in the global medical device outsourcing market.

North America dominates the global medical device outsourcing market, primarily attributed to the rising number of chronic disorders, such as cardiac and neurological. According to WHO, it was estimated that coronary artery disease (CAD) was responsible for a total of 11.1 million deaths globally in 2020.

Increasing expenditure on healthcare and raising awareness among people are also contributing to the market's growth in this region. The presence of a large number of medical device manufacturers and the availability of advanced healthcare systems and manufacturing hubs for high-end, consistent, and complex medical devices in this region are contributing to the growth of the medical device outsourcing market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Apr 2022, Integer Holdings Corporation acquired Connemara Biomedical Holdings Teoranta along with its subsidiaries (Aran Biomedical & Proxy Biomedical). Aran is a high-precision biomaterial coating and advanced metal and polymer manufacturer for and provides solutions for implantable medical devices developing and manufacturing.

Competitive Landscape

The medical device outsourcing market is moderately competitive with local and global companies' presence. Integer Holdings Corporation, Thermo Fisher Scientific, Nortech Systems, Inc., Plexus Corp., West Pharmaceutical Services, Inc, Celestica, Inc, Intertek Group, Wuxi Apptec, IQVIA Holdings, Benchmark Electronic Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Apr 2021, IQVIA Holdings Inc., technology solutions, analytical and clinical research service provider, announced that it completely acquired Q2 Solutions, a clinical laboratory services organization, from Quest Diagnostics, a diagnostic information service provider. It already acquired 60% of the shares and now has acquired the remaining 40% of the minority shares resulting in 100% IQVIA's ownership.

Integer Holdings Corporation.

Overview: Integer Holdings is a medical device outsourcing company that serves various markets, such as cardiac, vascular, neuromodulation and portable medical markets. It provides a novel, innovative technologies with high quality to the medical device industry. It was established in 1940 and is headquartered in Texas, United States.

Product Portfolio:

QHR high-rate primary cells: These are commonly used for treating tachycardia in cardiac rhythm devices and for giving effective therapy in other implantable applications that need pulse currents of ampere-level. This QHR hybrid cathode technology is specially designed to provide high device performance and longevity in a small size.

Key Development: In Dec 2021, Integer Holdings Corporation, a manufacturer of medical device outsourcing, announced that it had completely acquired Oscor, Inc., a private company designing, developing and producing a portfolio of highly specific implantable devices, medical devices, and diagnostic catheters.

The global medical device outsourcing market report would provide access to approx. 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Reducing production cost
      • 4.1.1.2. Expansion of manufacturing facilities
    • 4.1.2. Restraints:
      • 4.1.2.1. Threat of loss of confidential information
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Raw Material *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Electronics
  • 7.4. Finished Goods

8. By Device Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 8.1.2. Market Attractiveness Index, By Device Type
  • 8.2. Class I *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Class II
  • 8.4. Class III

9. By Services

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 9.1.2. Market Attractiveness Index, By Services
  • 9.2. Contract Device Manufacturing *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Prototype Development
  • 9.4. Clinic Research & Regulatory Support Services
  • 9.5. Product Design and Development
  • 9.6. Product Testing
  • 9.7. Assembly & Packaging
  • 9.8. Quality Assurance
  • 9.9. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Cardiovascular *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Orthopedic & Spine
  • 10.4. Radiology
  • 10.5. Drug Delivery
  • 10.6. Ophthalmic
  • 10.7. General Medical Devices
  • 10.8. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Device Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Services
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Integer Holdings Corporation
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Thermo Fisher Scientific
  • 13.3. Nortech Systems, Inc.
  • 13.4. Plexus Corp.
  • 13.5. West Pharmaceutical Services, Inc
  • 13.6. Celestica, Inc
  • 13.7. Intertek Group
  • 13.8. Wuxi Apptec
  • 13.9. IQVIA Holdings
  • 13.10. Benchmark Electronic Inc.

LIST NOT EXHAUSTIVE

14. Global Medical Device Outsourcing Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us